At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Blood Draws +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Observational, Multicenter Study to Evaluate Interferon Gamma (IFNγ) and Other Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis (M-HLH)
In Brief
An observational study evaluating Blood Draws and Data Collection for Hemophagocytic Lymphohistiocytosis. Completed, enrolled 40 participants across 1 site.
Detailed Summary
This observational study is designed to determine the levels of pro-inflammatory markers in patients diagnosed with M-HLH, and to assess whether the cytokine profiles bear an IFNγ signature.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHemophagocytic Lymphohistiocytosis
CountriesUnited States
CollaboratorsM.D. Anderson Cancer Center
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartOct 2016
First PostedAug 2017
Primary CompletionJan 2020
TodayJul 2026
First PostedAug 23, 2017
Enrollment StartOct 13, 2016
Primary CompletionJan 29, 2020
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 8.9 years ago
Interventions
Blood Drawsother
Data Collectionother